Toward 3D‐Bioprinted Models of the Liver to Boost Drug Development

G Guagliano, C Volpini… - Macromolecular …, 2022 - Wiley Online Library
The main problems in drug development are connected to enormous costs related to the
paltry success rate. The current situation empowered the development of high‐throughput …
被引用次数：13 相关文章

Toward 3D‐Bioprinted Models of the Liver to Boost Drug Development

G Guagliano, C Volpini, F Briatico‐vangosa… - MACROMOLECULAR …, 2022 - iris.unipv.it
The main problems in drug development are connected to enormous costs related to the
paltry success rate. The current situation empowered the development of high-throughput …
[PDF] researchgate.net

[PDF][PDF] Toward 3D-Bioprinted Models of the Liver to Boost Drug Development

G Guagliano, C Volpini, F Briatico-Vangosa… - 2022 - researchgate.net
The development of a new active pharmaceutical ingredient (API) must be subjected to a
strictly regulated process, before reaching the market (Figure 1). This procedure ensures the …

Toward 3D-Bioprinted Models of the Liver to Boost Drug Development

G Guagliano, C Volpini… - …, 2022 - re.public.polimi.it
The main problems in drug development are connected to enormous costs related to the
paltry success rate. The current situation empowered the development of high-throughput …

Towards 3D-bioprinted Models of the Liver to Boost Drug Development.

G Guagliano, C Volpini, F Briatico-Vangosa… - Macromolecular …, 2022 - europepmc.org
The main problems in drug development are connected to enormous costs related to the
paltry success rate. The current situation empowered the development of high-throughput …

Toward 3D-Bioprinted Models of the Liver to Boost Drug Development

G Guagliano, C Volpini… - Macromolecular …, 2022 - pubmed.ncbi.nlm.nih.gov
The main problems in drug development are connected to enormous costs related to the
paltry success rate. The current situation empowered the development of high-throughput …